GlassScriptPhysician profile
Susan Barasch
NPI 1578556437
$330.90
in general payments reported to CMS, 2019-2025
12 companies · $46.96 in 2025
The $46.96 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $39.22 · 2021: $15.00 · 2022: $26.63 · 2023: $33.13 · 2024: $62.89 · 2025: $46.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $59.43 | 2020-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Sanofi Pasteur INC. | $48.50 | 2019-2023 | |
| Pfizer INC. | $42.92 | 2019-2025 | |
| Cranial Technologies, INC | $42.35 | 2019-2025 | Doc Band |
| Baxter Healthcare | $26.63 | 2022 | |
| Boston Scientific Corporation | $23.83 | 2019 | |
| Allergan, INC. | $16.66 | 2019 | |
| Alk-Abello, INC | $15.80 | 2024 | Ragwitek, Grastek, Odactra |
| Kaleo, INC. | $15.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.16 | 2025 | Zoryve |
| Seqirus USA INC | $13.16 | 2023 | Flucelvax Quadrivalent |
| Genentech USA, INC. | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Barasch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.